Oliveros, Charilyn C.
HRN: 23-88-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
CEFUROXIME 1.5GM (VIAL)
10/12/2023
10/19/2023
IVT
1.5GGMS
Q 8 HRS
PROMX10 HRS; TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes